Tag: CBT > Medical Cannabis Research Cannabinoids: Page 3

Hemp Research

Preliminary Studies Show Cannabinoids Could Ward Off COVID-19. Will They Live Up to Their Potential?

Recent research from several universities highlights the promise of cannabinoids in fighting off coronavirus through various phases of infection, but experts warn the studies are still too preliminary to draw conclusions.

January 24, 2022

Utah

Pfizer Enters $6.7-Billion Acquisition Deal With Cannabis Pipeline

The American multinational pharmaceutical and biotechnology company signed an agreement with clinical-stage company Arena Pharmaceuticals.

December 21, 2021

International

Global Companies Expand Work on Cannabis-Based Epilepsy Treatments

Representatives of companies with global footprints discuss the goals behind the research, governmental approval and sale of cannabis compounds for epileptic conditions.

December 3, 2021

Top Stories

The Problem with 'Indica' and 'Sativa' on Cannabis Labels: New Report

Genetic testing reveals that those terms don’t correlate in any meaningful way with the effect of the plant’s chemistry.

October 20, 2021

Home

THC-O Acetate: ‘Potent is Not Necessarily Better’

Renowned cannabis and endocannabinoid researcher Dr. Ethan Russo weighs in on the realities and legalities of the cannabinoid THC-O acetate.

September 8, 2021

California

Clever Leaves and Biopharmaceutical Research Company to Partner for Landmark Cannabis Research Study in Collaboration With University of California, Davis

The initiative is part of Project Change Lives; Clever Leaves’ $25M product pledge to aid cannabis research in the U.S. The collaboration represents the company’s first funded study with a research institution in the U.S.

July 27, 2021

Nevada

‘This is Going to Change the Way People Think About Medicine’: Q&A with Dr. Andrea Small-Howard

Chief Science Officer and recently appointed GB Sciences President Dr. Andrea Small-Howard details the company’s latest research in cannabis-based treatments for Parkinson’s disease and pain, and how it is using AI technology to bring novel medicines to market.

July 19, 2021

Hemp

NFL, Players Association Provide $1 Million for Cannabinoid Research on Pain Management

The funding will explore alternatives to opioids, including cannabis and its derivatives.

June 9, 2021

Interviews & Opinion

HeroGrown’s Mission Continues After Death of Co-Founder Roger Martin

Nick Martin, Roger’s son and HeroGrown co-founder, talks about continuing the father-son team’s mission to save ‘as many heroes’ as it can using cannabis.

May 11, 2021

Cannabinoid Discovery

Minor Cannabinoid Research Roundup

A look at what 2020 taught us about CBC, CBN, CBG and THCV.

December 22, 2020

Compliance

Researchers Develop Test to Determine Cannabinoid Dominance in Cannabis

A University of Minnesota research team has developed a genetic test that can predict whether cannabis will produce mostly CBD or THC, having broad implications for both cannabis and hemp.

December 8, 2020

Finance

R&D Tax Credit: A Viable Option to Reduce Tax Burdens?

Proper planning and corporate structuring can help cannabis and hemp companies find tax savings despite 280E restrictions.

December 3, 2020